Diagnosis of Coronary Artery Disease in Women

Progress in Cardiovascular Diseases

Volumn 46, Issue 3, 2003, Pages 239-258

  Redberg, Rita F ^a   Shaw, Leslee J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EXERCISE TEST; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PRACTICE GUIDELINE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

EID: 0346880227     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2003.09.002     Document Type: Article

References (109)

1. Chaitman BR, Bourassa MG, Davis K, et al: Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation 64:360-367, 1981
2. Kwok Y, Kim C, Grady D, et al: Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83:660-666, 1999
3. Douglas PS, Ginsburg GS: The evaluation of chest pain in women. N Engl J Med 334:1311-1315, 1996
4. Lerner DJ, Kannel WB: Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383-390, 1986
5. Barrett-Connor EL, Cohn BA, Wingard DL, et al: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631, 1991
6. Weiner DA, Ryan TJ, McCabe CH, et al: Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med 301:230-235, 1979
7. Diamond GA, Forrester JS: Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 300:1350-13658, 1979
8. Pryor DB, Harrell FE Jr, Lee KL, et al: Estimating the likelihood of significant coronary artery disease. Am J Med 75:771-780, 1983
9. Ayanian JZ, Epstein AM: Attitudes about treatment of coronary heart disease among women and men presenting for exercise testing. J Gen Intern Med 12:311-114, 1997
10. Gibbons RJ, Balady GJ, Bricker JT, et al: ACC/AHA 2002 Guideline Update for Exercise Testing - Summary Article. J Am Coll Cardiol 106:1883-1892, 2002
11. Sackett D, Haynes R, Guyatt G, et al: Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, MA, Little, Brown, 1991
12. Roger VL, Pellikka PA, Bell MR, et al: Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation 95:405-410, 1997
13. Douglas PS: Is noninvasive testing for coronary artery disease accurate? Circulation 95:299-302, 1997
14. Diamond GA: Off Bayes: Effect of verification bias on posterior probabilities calculated using Bayes' theorem. Med Decis Making 12:22-31, 1992
15. Hunink M, Begg C: Diamond's correction method - a real gem or just cubic zirconium? Med Decis Making 11:201-203, 1991
16. Alexander KP, Shaw LJ, Shaw LK, et al: Value of exercise treadmill testing in women. J Am Coll Cardiol 32:1657-1664, 1998
17. Okin PM, Kligfield P: Gender-specific criteria and performance of the exercise electrocardiogram. Circulation 92:1209-1216, 1995
18. Morise AP, Duval RD: Accuracy of ST/heart rate index in the diagnosis of coronary artery disease. Am J Cardiol 69:603-606, 1992
19. Mark DB: An overview of risk assessment in coronary artery disease. N Engl J Med 330:1101-1106, 1994
20. Hachamovitch R, Berman DS, Kiat H, et al: Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93:905-914, 1996
21. Shaw LJ, Hachamovitch R, Iskandrian AE: Treadmill test scores: attributes and limitations. J Nucl Cardiol 4:74-78, 1997
22. Shaw LJ, Peterson ED, Shaw LK, et al: Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 98:1622-1630, 1998
23. Agency for Healthcare Research and Quality. Diagnosis and treatment of coronary heart disease in women: Systematic reviews of evidence on selected topics. Summary, evidence report/technology assessment: Number 81. AHRQ Publication No. 03-E036, May 2003. Available from: http://www.ahrq.gov/clinic/epcsums/chdwtopsum.htm
24. Agency for Healthcare Research and Quality. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Summary, evidence report/technology assessment: Number 80. AHRQ Publication No. 03-E034, May 2003. Available from: http://www.ahrq.gov/clinic/epcsums/chdwomsum.htm
25. Fleischmann KE, Hunink MG, Kuntz KM, et al: Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 280:913-920, 1998
26. Gianrossi R, Detrano R, Mulvihill D, et al: Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 80:87-98, 1989
27. Sketch MH, Mohiuddin SM, Lynch JD, et al: Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms. Am J Cardiol 36:169-173, 1975
28. Pashkow F: Role of routine exercise electrocardiographic testing, in Marwick T (ed): Cardiac Stressing & Imaging: A Clinician's Guide. New York, NY, Churchill Livingstone, pp 1-31, 1996
29. Kim C, Kwok YS, Saha S, et al: Diagnosis of suspected coronary artery disease in women: A cost-effectiveness analysis. Am Heart J 137:1019-1027, 1999
30. Mieres J, Shaw LJ, Hendel RC, et al: Consensus statement: American Society of Nuclear Cardiology: Task force on women and coronary artery disease - The role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women. J Nucl Cardiol 10:95-101, 2003
31. Kosa I, Ziegler S, Nekolla S, et al: Principals and methods of myocardial perfusion imaging, in Marwick T (ed): Cardiac Stress Testing & Imaging: A Clinician's Guide. New York, NY, Churchill Livingstone, 1996
32. Hansen CL, Crabbe D, Rubin S: Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol 28:1214-1219, 1996
33. Grover-McKay M: Gender-related imaging issues in assessment of coronary artery disease by nuclear techniques. Am J Card Imaging 10:54-64, 1996
34. Bonow RO: Functional evaluation of patients with coronary artery disease: Selection of appropriate pharmacologic agents and imaging modalities. Eur Heart J 16:11-6, 1995 (Suppl M)
35. Wilson RF, Wyche K, Christensen BV, et al: Effects of adenosine on human coronary arterial circulation. Circulation 82:1595-606, 1990
36. Granato JE, Watson DD, Belardinelli L, et al: Effects of dipyridamole and aminophylline on hemodynamics, regional myocardial blood flow and thallium-201 washout in the setting of a critical coronary stenosis. J Am Coll Cardiol 16:1760-1770, 1990
37. Armstrong WF, Bach DS: Clinical and diagnostic utility of arbutamine for cardiovascular stress testing during echocardiographic monitoring. Eur Heart J 16:24-27, 1995 (Suppl M)
38. Cohen JL, Chan KL, Jaarsma W, et al: Arbutamine echocardiography: Efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The International Arbutamine Study Group. J Am Coll Cardiol 26:1168-1175, 1995
39. Cohen A, Weber H, Chauvel C, et al: Comparison of arbutamine and exercise echocardiography in diagnosing myocardial ischemia. Am J Cardiol 79:713-716, 1997
40. Dennis CA, Pool PE, Perrins EJ, et al: Stress testing with closed-loop arbutamine as an alternative to exercise. The International Arbutamine Study Group. J Am Coll Cardiol 26:1151-1158, 1995
41. Ginzton LE, Pool PE, Appleton C, et al: Arbutamine vs. exercise stress testing in patients with coronary artery disease: Evaluation by echocardiography and electrocardiography. Int J Cardiol 57:81-89
42. Ketteler T, Krahwinkel W, Wolfertz J, et al: Arbutamine stress echocardiography. Eur Heart J 18: D24-D30, 1997 (Suppl D)
43. Khattar RS, Senior R, Joseph D, et al: Comparison of arbutamine stress 99mTc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia. J Nucl Cardiol 4:211-216, 1997
44. Orlandi C: Pharmacology of coronary vasodilation: a brief review. J Nucl Cardiol 1996:S27-S30, 1996
45. Kiat H, Iskandrian AS, Villegas BJ, et al: Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy. The International Arbutamine Study Group. J Am Coll Cardiol 26: 1159-1167, 1995
46. Meyer SL, Curry GC, Donsky MS, et al: Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 38:103-108, 1976
47. Lima RS, Watson DD, Goode AR, et al: Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 42:64-70, 2003
48. Kong BA, Shaw L, Miller DD, et al: Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Am J Cardiol 70:168-173, 1992
49. Kwok Y, Kim C, Redberg R: Meta-analysis of pharmacologic stress testing for coronary artery disease diagnosis. Am Heart J 142:934-944, 2001
50. Shaw LP: Noninvasive stress testing. Coronary artery disease in women: what all physicians need to know. American College of Physicians-American Society of Internal Medicine 1999, pp 327-350
51. Taillefer R, DePuey EG, Udelson JE, et al: Comparative diagnostic accuracy of TI-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 29:69-77, 1997
52. Detrano R, Janosi A, Lyons KP, et al: Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram. Am J Med 84:699-710, 1988
53. Ryan T: Left ventricular functional response to stress for the diagnosis of CAD, in Marwick T (ed): Cardiac Stress Testing & Imaging: A Clinician's Guide. New York, NY, Churchill Livingstone, 1996
54. Flachskampf FA, Lethen H, Hoffmann R, et al: Transoesophageal stress echocardiography. Eur Heart J 18:D37-42, 1997 (Suppl D)
55. Cohen JL, Cheirif J, Segar DS, et al: Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol 32:746-752, 1998
56. Marwick TH, Anderson T, Williams MJ, et al: Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 26:335-341, 1995
57. Lewis JF, Lin L, McGorray S, et al: Dobutamine stress echocardiography in women with chest pain: pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). J Am Coll Cardiol 33:1462-1468, 1999
58. Amanullah AM, Berman DS, Erel J, et al: Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 82:725-730, 1998
59. Geleijnse ML, Elhendy A, van Domburg RT, et al: Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 77:1057-1061, 1996
60. Hachamovitch R, Berman DS, Kiat H, et al: Effective risk stratification using exercise myocardial perfusion SPECT in women: Gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 28:34-44, 1996
61. Poldermans D, Fioretti PM, Boersma E, et al: Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation 99:757-762, 1999
62. Travin MI, Duca MD, Kline GM, et al: Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 134:73-82, 1997
63. Heupler S, Mehta R, Lobo A, et al: Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 30:414-420, 1997
64. Cortigiani L, Dodi C, Paolini EA, et al: Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 32:1975-1981, 1998
65. Arruda-Olson AM, Juracan EM, Mahoney DW, et al: Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol 39:625-631, 2002
66. Detrano R, Hsiai T, Wang S, et al: Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography [see comments]. J Am Coll Cardiol 27:285-290, 1996
67. Marwick TH, Shaw LJ, Lauer MS, et al: The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 106:172-178, 1999
68. Shaw L, Lewin HC, Berman DS, et al: Diagnostic and prognostic risk stratification in 7,024 women undergoing SPECT imaging: results from a multicenter prospective registry. J Nucl Med 39:115P, 1998
69. Taylor AJ, Merz CN, Udelson JE: 34th Bethesda Conference: Executive summary - can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J Am Coll Cardiol 41:1855-1917, 2003
70. Blankenhorn D: Calcification of the Coronary Arteries. Am J Roentgenol Radium Ther Nucl Med 81: 772-777, 1959
71. Budoff MJ, Georgiou D, Brody A, et al: Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 93:898-904, 1996
72. Doherty TM, Detrano RC, Mautner SL, et al: Coronary calcium: the good, the bad, and the uncertain. Am Heart J 137:806-814, 1999
73. Guerci AD, Spadaro LA, Goodman KJ, et al: Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease. J Am Coll Cardiol 32:673-679, 1997
74. Kennedy J, Shavelle R, Wang S, et al: Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J 135:696-702, 1998
75. Achenbach S, Ropers D, Pohle K, et al: Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation. Circulation 106:1077-1082, 2002
76. Callister TQ, Raggi P, Cooil B, et al: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339:1972-1978, 1998
77. Raggi P, Cooil B, Shaw LJ, et al: Progression of coronary calcification on serial electron beam tomography scanning is greater in patients with future myocardial infarction. Am J Cardiol 92:827-829, 2003
78. O'Rourke RA, Brundage BH, Froelicher VF, et al: American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 36:326-340, 2000
79. Rumberger JA, Sheedy PF 3rd, et al: Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram. Effect of patient's sex on diagnosis. Circulation 91: 1363-1367, 1995
80. Devries S, Wolfkiel C, Fusman B, et al: Influence of age and gender on the presence of coronary calcium detected by ultrafast computed tomography. J Am Coll Cardiol 25:76-82, 1995
81. Morise AP, Dalal JN, Duval RD: Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women. Am J Med 94:491-496, 1993
82. Kaufmann RB, Sheedy PN, Maher JE, et al: Quantity of coronary artery calcium detected by electron beam computed tomography in asymptomatic subjects and angiographically studied patients. Mayo Clin Proc 70:223-232, 1995
83. Wong ND, Vo A, Abrahamson D, et al: Detection of coronary artery calcium by ultrafast computed tomography and its relation to clinical evidence of coronary artery disease. Am J Cardiol 73:223-227, 1994
84. Agatston AS, Janowitz WR, Hildner FJ, et al: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832, 1990
85. Kajinami K, Seki H, Takekoshi N, et al: Coronary calcification and coronary atherosclerosis: Site by site comparative morphologic study of electron beam computed tomography and coronary angiography. J Am Coll Cardiol 29:1549-1556, 1997
86. Achenbach S, Moshage W, Ropers D, et al: Value of electron-beam computed tomography for the non-invasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med 339:1964-1971, 1998
87. Sardanelli F, Molinari G, Zandrino F, et al: Three-dimensional, navigator-echo MR coronary angiography in detecting stenoses of the major epicardial vessels, with conventional coronary angiography as the standard of reference. Radiology 214:808-814, 2000
88. Fayad ZA, Fuster V, Fallon JT, et al: Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 102:506-510, 2000
89. Toussaint JF, LaMuraglia GM, Southern JF, et al: Magnetic resonance images lipid, fibrous, calcified hemorrhagic and thrombotic components of human atherosclerosis in vivo. Circulation 94:932-938, 1996
90. McConnell MV, Aikawa M, Maier SE, et al: MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 19: 1956-1959, 1999
91. Skinner MP, Yuan C, Mitsumori L, et al: Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure progression and complications in vivo. Nat Med 1:69-73, 1995
92. Worthley SG, Helft G, Fuster V, et al: Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation 101:586-589, 2000
93. Helft G, Worthley SG, Fuster V, et al: In vivo quantification of atherosclerotic plaque composition by noninvasive high resolution MRI in rabbits: A histopathological correlation. J Am Coll Cardiol 35:47BA, 2000
94. Worthley SG, Helft G, Fuster V, et al: Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation 101:2956-2961, 2000
95. Fayad ZA, Fallon JT, Shinnar M, et al: Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 98:1541-1547, 1998
96. Budoff MJ, Gillespie R, Georgiou D, et al: Comparison of exercise electron beam computed tomography and sestamibi in the evaluation of coronary artery disease. Am J Cardiol 81:682-687, 1998
97. Nagel E, Lehmkuhl HB, Bocksch W, et al: Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99:763-770, 1999
98. Keijer JT, van Rossum AC, van Eenige MJ, et al: Magnetic resonance imaging of regional perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201) Thallium-SPECT and coronary angiography. J Magn Reson Imaging 11:607-615, 2000
99. Pohost GM, Buchthal SD, Johnson BD, et al: Abnormal 31P NMR stress test is predictive of myocardial events: a report from the NIH-NHLBI sponsored women's ischemia syndrome evaluation (WISE). J Am Coll Cardiol 39:455A, 2002
100. Panting JR, Gatehouse PD, Yang GZ, et al: Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346:1948-1953, 2002
101. Marwick TH, Shaw LJ, Case C, et al: Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice. Eur Heart J 24:1153-1163, 2003
102. Shaw LJ, Marwick TH, Lauer M, et al: Prognostic value of exercise echocardiography vs. SPECT imaging in 9,521 intermediate pretest risk patients. Circulation 106:11-610, 2002
103. Shaw LJ, Heller GV, Travin MI, et al: Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain: Economics of Non-invasive Diagnosis (END) Study Group. J Nucl Cardiol 6:559-569, 1999
104. Merz NB, Johnson BD, Kelsey PSF, et al: Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care 7:959-965, 2001
105. Shaw L, Heller G, Taravin M, et al: Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. J Nucl Cardiol 6:559-569, 1999
106. Mark DB, Shaw LJ, Lauer MS, et al: 34th Bethesda Conference: Task force #5 - Is atherosclerotic imaging cost-effective? From the 34th Bethesda Conference on Atherosclerotic Imaging. J Am Coll Cardiol 41:1906-1917, 2003
107. Iskandrian AE, Heo J, Nallamothu N: Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol 4:329-335, 1997
108. Rozanski A, Diamond GA, Berman D, et al: The declining specificity of exercise radionuclide ventriculography. N Engl J Med 309:518-522, 1983
109. Ho YL, Wu CC, Huang PJ, et al: Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 135:655-662, 1998